Update: Eli Lilly Says Its Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial
Update: Eli Lilly Says Its Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial
更新：禮來公司表示，Zepbound在第三階段試驗中對比Wegovy顯示出47%的 "相對體重減輕"。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊